Previous Section
Drug Therapy
1. Treatment of inflammatory immunologic disease 4. B cell targeting therapy using the anti-CD20 antibody rituximab in inflammatory autoimmune diseases.
- Author
- Tanaka Y;
- Institution
- The First Department of Internal Medicine, School of Medicine, University of Occupational & Environmental Health, Japan. tanaka@med.uoeh-u.ac.jp <tanaka@med.uoeh-u.ac.jp>
- Journal
- Intern Med. 2007;46(16):1313-5. Epub 2007 Aug 15.
2. Drug Insight: resistance to methotrexate and other disease-modifying antirheumatic drugs--from bench to bedside.
- Author
- van der Heijden JW; Dijkmans BA; Scheper RJ; Jansen G;
- Institution
- Department of Rheumatology, VU University Medical Center, Amsterdam, The Netherlands.
- Journal
- Nat Clin Pract Rheumatol. 2007 Jan;3(1):26-34.
- Abstract URL
- Click here to view abstract
3. Effects of glucocorticoids on radiological progression in rheumatoid arthritis.
- Author
- Kirwan JR; Bijlsma JW; Boers M; Shea BJ;
- Institution
- Liverpool Women's Hospital, Crown Street, Liverpool, UK, L8 7SS. John.Kirwan@lwh-tr.nwest.nhs.uk
- Journal
- Cochrane Database Syst Rev. 2007 Jan 24;(1):CD006356.
- Abstract URL
- Click here to view abstract
4. Clinical practice format for choosing a second-line disease modifying anti-rheumatic drug in early rheumatoid arthritis after failure of 6 months' first-line DMARD therapy.
- Author
- Meyer O; de Bandt M; Berthelot JM; Cantagrel A; Combe B; Fautrel B; Flipo RM; Liote F; Maillefert JF; Saraux A; Wendling D; Guillemin F; Le Loet X;
- Institution
- Department of Rheumatology, AP-HP, Bichat Paris 7 University Hospital, CHU Bichat, 46 rue Henri Huchard, 75018 Paris, France. olivier.meyer@bch.aphp.fr
- Journal
- Joint Bone Spine. 2007 Jan;74(1):73-8. Epub 2006 Nov 29.
- Abstract URL
- Click here to view abstract
5. Incidence of melanoma and other malignancies among rheumatoid arthritis patients treated with methotrexate.
- Author
- Buchbinder R; Barber M; Heuzenroeder L; Wluka AE; Giles G; Hall S; Harkness A; Lewis D; Littlejohn G; Miller MH; Ryan PF; Jolley D;
- Institution
- Cabrini Hospital and Monash University, Melbourne, Victoria, Australia. rachelle.buchbinder@med.monash.edu.au
- Journal
- Arthritis Rheum. 2008 Jun 15;59(6):794-9.
- Abstract URL
- Click here to view abstract
6. The use of TNF-alpha blocking agents in rheumatoid arthritis: an update.
- Author
- Toussirot E; Wendling D;
- Institution
- University Hospital Jean Minjoz, Department of Rheumatology, Besancon cedex, France. etoussirot@chu-besancon.fr
- Journal
- Expert Opin Pharmacother. 2007 Sep;8(13):2089-107.
- Abstract URL
- Click here to view abstract
7. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis.
- Author
- Saag KG; Teng GG; Patkar NM; Anuntiyo J; Finney C; Curtis JR; Paulus HE; Mudano A; Pisu M; Elkins-Melton M; Outman R; Allison JJ; Almazor MS; Bridges SL Jr; Chatham WW; Hochberg M; MacLean C; Mikuls T; Moreland LW; O'Dell J; Turkiewicz AM; Furst DE;
- Institution
- University of Alabama, Birmingham, AL, USA.
- Journal
- Arthritis Rheum. 2008 Jun 15;59(6):762-84.
8. Drug insight: Anti-tumor necrosis factor therapy for inflammatory arthropathies during reproduction, pregnancy and lactation.
- Author
- Skomsvoll JF; Wallenius M; Koksvik HS; Rodevand E; Salvesen KA; Spigset O; Kvien TK; Skomsvoll JF; Wallenius M; Koksvik HS; Rodevand E; Salvesen KA; Spigset O; Kvien TK;
- Institution
- Department of Obstetrics, Trondheim University Hospital, Trondheim, Norway. johan.skomsvoll@ntnu.no
- Journal
- Nat Clin Pract Rheumatol. 2007 Mar;3(3):156-64.
- Abstract URL
- Click here to view abstract
9. Management of established rheumatoid arthritis with an emphasis on pharmacotherapy.
- Author
- Blom M; van Riel PL;
- Institution
- Department of Rheumatology, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB Nijmegen, The Netherlands. m.blom@reuma.umcn.nl
- Journal
- Best Pract Res Clin Rheumatol. 2007 Feb;21(1):43-57.
- Abstract URL
- Click here to view abstract
10. Risk: benefit profile of etanercept in elderly patients with rheumatoid arthritis, ankylosing spondylitis or psoriatic arthritis.
- Author
- Fleischmann R; Iqbal I; Fleischmann R; Iqbal I;
- Institution
- The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75235, USA. rfleischmann@arthdocs.com
- Journal
- Drugs Aging. 2007;24(3):239-54.
- Abstract URL
- Click here to view abstract
Next: Surgical Therapy
